BioSpace News Archive

The AmplideX® DM1 Dx Kit is now available in countries accepting the CE mark

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced the formation of a new Scientific Advisory Board (SAB), which is comprised of international experts in otolaryngology, pediatrics, and infectious diseases.

Three-in-five expect to gain weight over the holidays, one-third say they’ll gain 10 or more pounds

Assets Well Positioned to Create Substantial Value for Shareholders

The solution guides select patients to the right doctor based on provider scheduling rules

Leaders in the oncology industry are working relentlessly to develop a wide variety of treatments and applications for cancer.

Theravance Biopharma, Inc. will host an R&D Day from 12:00 p.m. ET to 3:00 p.m. ET on Wednesday, December 12, 2018, in New York City.

FN Media Group Presents Potstocknews.com Market Commentary FN Media Group Presents Potstocknews.com Market Commentary

Company leverages digital workspace solutions to fuel next-generation satellite launch platform, collaborate in space

Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the National Medical Products Administration (NMPA) has approved Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg) in China for the treatment of chronic hepatitis C virus (HCV) genotype 1-6 infection in adults and adolescents aged 12 to 18 years.